Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
| Actual shortage: | 217 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2017-04-07 | 2017-12-11 | 5888 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-04-12 | 2024-10-04 | 225101 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-05-30 | 2024-09-27 | 229161 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2020-08-05 | 2020-09-14 | 121768 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2021-03-05 | 2021-05-26 | 135148 |
| APO-APREMILAST | 30MG | TABLET | Resolved | 2025-01-24 | 2025-01-31 | 248558 |
| APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2025-02-13 | 2025-04-17 | 250307 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2025-02-13 | 2025-03-07 | 250313 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2025-02-13 | 2025-04-11 | 250322 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Actual shortage | 2025-04-04 | 2025-04-17 | 254159 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2025-01-16 | 2025-01-31 | 247894 |
| APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126234 |
| APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126239 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126242 |
| APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126245 |
| APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126248 |
| APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126251 |
| APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126254 |
| APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126257 |
| APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126260 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2025-01-10 | 2025-01-27 | 247469 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-AMITRIPTYLINE | 75MG | TABLET | To be discontinued | 2025-01-10 | 2025-01-10 | 247472 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2025-01-10 | 2025-01-11 | 247466 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2025-01-10 | 2025-01-11 | 247462 |